296 related articles for article (PubMed ID: 24300358)
1. Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
Derlin T; Clauditz TS; Bannas P
Clin Nucl Med; 2014 Feb; 39(2):188-9. PubMed ID: 24300358
[TBL] [Abstract][Full Text] [Related]
2. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
3. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Avery R; Kuo PH
Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
[TBL] [Abstract][Full Text] [Related]
4. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
7. Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
Xiao J; Wang D; Guo B; Wang L; Su M; Xu H
Nucl Med Commun; 2020 Sep; 41(9):942-949. PubMed ID: 32796483
[TBL] [Abstract][Full Text] [Related]
8. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.
Broos WAM; van der Zant FM; Wondergem M; Knol RJJ
Nucl Med Commun; 2018 Apr; 39(4):325-333. PubMed ID: 29351123
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of (18)F-labeled NaF positron emission tomography-computed tomography imaging in the detection of bone metastases in patients with lung cancer before treatment].
Wang XY; Rao LJ; Luo BQ; Chen ZF; Zhang XS; Shi XC; Yi C
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2495-8. PubMed ID: 23158718
[TBL] [Abstract][Full Text] [Related]
11. Technical feasibility, radiation dosimetry and clinical use of
Usmani S; Van den Wyngaert T; Ahmed N; Marafi F; Esmail A; Al Kandari F; Al Nuaimi M; Gnanasegaran G
Ann Nucl Med; 2018 Nov; 32(9):594-601. PubMed ID: 30019285
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
13. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
14. Observer Agreement and Accuracy of
Zacho HD; Fonager RF; Nielsen JB; Haarmark C; Hendel HW; Johansen MB; Mortensen JC; Petersen LJ
J Nucl Med; 2020 Mar; 61(3):344-349. PubMed ID: 31481577
[TBL] [Abstract][Full Text] [Related]
15. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
[TBL] [Abstract][Full Text] [Related]
16. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
Woodhead GJ; Avery RJ; Kuo PH
Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
[TBL] [Abstract][Full Text] [Related]
17. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Koo PJ; David Crawford E
Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
[TBL] [Abstract][Full Text] [Related]
18. The value of quantitative analysis in
Lapa P; Marques M; Costa G; Lima JP
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluoride PET/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience.
Tateishi U; Tateishi K; Shizukuishi K; Shishikura A; Murata H; Inoue T; Kawahara N
Clin Nucl Med; 2013 Mar; 38(3):e125-31. PubMed ID: 23412601
[TBL] [Abstract][Full Text] [Related]
20. Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Sampath SC; Sampath SC; Mosci C; Lutz AM; Willmann JK; Mittra ES; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Mar; 40(3):e173-7. PubMed ID: 25140557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
